Accelerating Innovation at Leica Biosystems

Summary Platform has evolved into higher growth, margin & recurring revenue portfolio indexed to most attractive end-markets Aldevron expands our capabilities into the important, fast- growing field of genomic medicine Enhancing our growth trajectory and long-term competitive advantage with high-impact organic & inorganic investments DANAHER

View entire presentation